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Introduction
More than 100 million African children are thought to be
anaemic (1), and community-based estimates of anaemia
prevalence (blood haemoglobin concentration (Hb) <11 g/dl)
in children in settings where malaria is endemic range between
49% and 76% (2–5). The consequences, in terms of years of
life lost, of such a high level of anaemia are hard to quantify,
although the burden of malaria-associated anaemia has been
estimated at 190 000–974 000 deaths per year in children
under 5 years of age (6). Certainly, children admitted to hos-
pital with severe anaemia (Hb <8 g/dl) are more likely to die
than children admitted without anaemia, and anaemia is
one of the largest killers of children admitted to hospital in
sub-Saharan Africa (7–9). Even where blood transfusions are
available there is a significant case fatality rate of 6–18%
(7, 10, 11). However, most children at high risk of severe
anaemia live beyond the easy reach of a hospital, the most
common type of health facility that can perform blood trans-
fusions.
The causes of anaemia are often multifactorial and are
interrelated in a complex way. First, the relative importance
of each factor — for example, hookworm or malaria —
varies in different settings (12, 13). Anaemia may be chro-
nic — for example, secondary to iron deficiency, infection
with human immunodeficiency virus (HIV), or intestinal
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Objective To document the prevalence, age-distribution, and risk factors for anaemia in Tanzanian children less than 5 years old,
thereby assisting in the development of effective strategies for controlling anaemia.
Methods Cluster sampling was used to identify 2417 households at random from four contiguous districts in south-eastern
United Republic of Tanzania in mid-1999. Data on various social and medical parameters were collected and analysed.
Findings Blood haemoglobin concentrations (Hb) were available for 1979 of the 2131 (93%) children identified and ranged
from 1.7 to 18.6 g/dl. Overall, 87% (1722) of children had an Hb <11 g/dl, 39% (775) had an Hb <8 g/dl and 3% (65) had an
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worms — or it may be acute, owing to a sickle-cell crisis or
Plasmodium falciparum infection, or chronic anaemia may
be acutely exacerbated. The situation is complicated further
because anaemia in childhood can result not only from
events in childhood but also from maternal iron deficiency
and anaemia, which are associated with impaired fetal devel-
opment and iron-deficient and anaemic babies (14–17).
Socioeconomic status may also affect the risk of anaemia by
affecting nutritional status, family size, and birth interval, as
well as intensifying problems of affordability and accessibi-
lity of preventive and curative measures. 
Studies in east Africa have shown that P. falciparum
malaria and iron deficiency account for much of the anaemia
seen in young children (18, 19). One randomized study con-
cluded that approximately 60% of anaemia in infancy could
be prevented by antimalarial chemoprophylaxis, illustrating
the importance of malaria as a cause of anaemia in this set-
ting (18). The same study also found that iron supplemen-
tation reduced the incidence of anaemia by about 30%. In
the same area, the prevalence of helminths in children under
5 was only 2% (20), and genetic causes of anaemia, such as
sickle-cell disease, were present, but at relatively low preva-
lences (18, 21). The public health importance of anaemia
resulting from HIV infection is not yet clear and is difficult
to quantify.
The control of anaemia depends largely on the diagnosis
and treatment of anaemia cases, rather than on the prevention
of anaemia. However, clinical examination for detecting
anaemia in young children is only moderately sensitive
(24–74% for an Hb <11 g/dl and 37–81% for an Hb <8 g/dl)
(22–29) and may be particularly problematic in very young
children examined by relatively poorly trained staff in the pri-
mary care setting (4–20%) (30). Various diagnostic tests exist
but all reliable approaches require some equipment that is not
readily available in many settings. In terms of prevention,
insecticide-treated mosquito nets (ITNs) have been shown to
improve haemoglobin concentration in children living in
malarious areas (31), but only recently has a potentially sus-
tainable approach to the distribution of ITNs been shown to
have similar effects (32). It will take some considerable time
before systems for the delivery of ITNs are functional on a
large scale. The WHO/UNICEF (United Nations Children’s
Fund) iron supplementation policy recommends daily iron
supplements starting at age 6 months for most children and
continuing up to 2 years (33). However, this policy is rarely
implemented due to the non-availability of a liquid ferrous
sulfate preparation and the absence of a mechanism to
deliver supplements to the target group.
Documenting the epidemiology of anaemia in United
Republic of African communities may offer fresh insights
into potential control strategies. With this in mind we report
a community-based survey in four districts of south-eastern
United Republic of Tanzania. 
Methods
The survey was conducted in the Kilombero, Morogoro
Rural, Rufiji, and Ulanga districts of south-eastern United
Republic of Tanzania. The area has been described in detail
elsewhere (34). Briefly, the predominantly low-lying area
extends west from the Indian Ocean south of Dar es Salaam,
punctuated by the Uluguru and Udzungwa mountains,
which rise in a crescent through the area. A long rainy sea-
son from March to June is followed by dry and dusty
months until November/ December when light rains return.
The area is holoendemic for malaria. The multi-ethnic
people are predominantly subsistence farmers of rice and
maize. Infant mortality ranges from 93 to 117 per 1000 live
births and the under-five mortality risk (5q0) is 124–183
per 1000 children (34). 
This survey was the baseline household survey of the
WHO Multi-Country Evaluation (MCE) of the Integrated
Management of Childhood Illness (IMCI) in the United
Republic of Tanzania. At the time of this study Rufiji and
Morogoro Rural districts were in the early stages of imple-
menting IMCI. Cluster samples were taken from the whole
of the four districts, and the probability of choosing a par-
ticular village was proportional to the size of its population.
In accordance with sample size calculations for the IMCI
evaluation, 30 rural clusters were chosen from each of the
Rufiji, Morogoro Rural, Kilombero, and Ulanga districts; in
Kilombero, five additional clusters were selected from the
semi-urban centre of Ifakara. Within each selected village 20
households were chosen according to a standardized proce-
dure that gave every household the same probability of being
included (details available on request). The purpose of the
study was explained to at least one member of each house-
hold and verbal consent was requested to proceed with the
interview. A standard questionnaire was completed for all
children under 5 years of age. The questionnaire developed
by WHO for the IMCI MCE (35) was locally adapted and
is available on request. The first section documented details
of all children in the household, information on household
socioeconomic status, and the educational level and occupa-
tion of the household head. Mothers were interviewed at
home about their educational level and that of the house-
hold head, breastfeeding practices, exposure to nutritional
counselling, knowledge of caring for a sick child, and about
any illness the child had experienced during the two weeks
before the survey, including the mother’s subjective assess-
ment of its severity and any action she took. The use of a
mosquito net for the child, and the child’s vaccination histo-
ry and vitamin A supplementation status were also docu-
mented. For children who had been sick, additional modules
documented detailed information about the use of health
services and drugs. 
Children were then invited to attend a measuring
station set up in the middle of the cluster where they were
weighed on digital scales (Seca Vogel & Halke GmbH,
Hamburg, Germany) and their height (>2 years) or length
(<2 years old) was measured using purpose-made instru-
ments. The location of the measuring station was docu-
mented using a handheld global positioning system (Garmin
GPS 12, GARMIN International, Lenexa, KS, USA),
enabling the distance from the cluster to the nearest
transfusion centre to be estimated. A finger-prick sample of
blood was collected and haemoglobin concentration
measured using a battery-powered HemoCue photometer
(HemoCue AB, Angelholm, Sweden). Children found to be
anaemic (Hb <11 g/dl) were dispensed the standard
Tanzanian IMCI anaemia treatment (a 14-day course of
ferrous sulfate, treatment courses of sulfadoxine-
pyrimethamine/chloroquine and mebendazole, depending
on age, whether febrile, and treatment history). All anaemic
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996 (50.3)c
983 (49.7)
40 (2)
221 (11.2)
226 (11.4)
403 (20.4)
377 (19.1)
389 (19.7)
322 (16.3)
1437 (77)
423 (23)
328 (82)
73 (18)
386 (20)
383 (20)
386 (20)
385 (20)
388 (20)
613 (33)
639 (34)
621 (33)
639 (33)
658 (34)
650 (33)
623 (33)
644 (34)
626 (33)
237 (12)
421 (21)
1312 (67)
1791 (91)
188 (9)
359/1979 (18)
1340 (68)
280 (14)
Gender (n=1979)        
Male
Female
Age (n=1979) 
<1 month
1–5 months
6–11 months
1 year
2 years
3 years
4 years
Time taken to travel from home to health
facility (n=1860)
90 minutes
>90 minutes
Fully vaccinated (n=401)
Yes
No
Socioeconomic score (n=1928) 
Most poor
Very poor
Poor
Less poor
Least poor
HAZe tertile (n=1873) 
Top 
Middle 
Bottom
WAZf tertile (n=1947)  
Top
Middle
Bottom
WHZg tertile (n=1893)  
Top 
Middle 
Bottom
Mosquito net (n=1970)
Treated
Untreated
None
Altitude (n=1979)
<1000 m
>1000 m
Distance to transfusion centre (n=1979) 
<10 km
10–49 km
>50 km
8.5; 0.10d
8.6; 0.10
P=0.26
13.5; 0.40
8.5; 0.18
7.6; 0.16
8.0; 0.14
8.3; 0.13
9.0; 0.13
9.2; 0.11
P=0.009
8.6; 0.09
8.6; 0.17
P=0.9
7.9; 0.14
8.1; 0.27
P=0.5
8.4; 0.14
8.4; 0.14
8.6; 0.18
8.7; 0.15
8.6; 0.16
P=0.07
8.8; 0.12
8.5; 0.10
8.4; 0.11
P=0.01
8.9; 0.11
8.6; 0.12
8.2; 0.11
P<0.00001
8.6; 0.12
8.7; 0.11
8.3; 0.11
P=0.004
8.8; 0.17
8.7; 0.15
8.5; 0.10
P=0.043
8.5; 0.09
9.1; 0.28
P=0.045
9.0; 0.18
8.5; 0.11
8.3; 0.25
P=0.0085
405 (41)c
368 (38)
P=0.18
1 (2)
89 (40)
133 (59)
207 (51)
157 (42)
112 (29)
75 (23)
P<0.00001
569 (40)
166 (39)
P=0.9
172 (52)
35 (48)
P=0.5
165 (45)
153 (42)
132 (38)
136 (37)
126 (37)
P=0.029
212 (35)
263 (41)
256 (41)
P=0.02
203 (32)
255 (39)
301 (46)
P<0.00001
224 (36)
238 (37)
282 (45)
P=0.004
71 (30)
150 (36)
551 (42)
P=0.005
719 (40)
56 (30)
P=0.20
101 (28)
547 (41)
127 (45)
P=0.001
28 (2.8)c
37 (3.8)
P=0.2
0 (0.0)
11 (5.0)
22 (9.7)
18 (4.5)
9 (2.4)
3 (0.8)
2 (0.6)
P<0.00001
42 (2.9)
18 (4.3)
P=0.25
14 (4.3)
4 (5.5)
P=0.6
18 (5.0)
12 (3.3)
12 (3.4)
2 (0.5)
13 (3.8)
P=0.23
21 (3.4)
14 (2.2)
25 (4.0)
P=0.6
14 (2.2)
19 (2.9)
28 (4.3)
P=0.02
9 (1.4)
21 (3.3)
29 (4.6)
P=0.006
3 (1.3)
7 (1.7)
55 (4.2)
P=0.03
64 (3.6)
1 (0.5)
P=0.02
3 (0.8)
50 (3.7)
12 (4.3)
P=0.03
Table 1. Descriptive data and risk factors for anaemia in Tanzanian childrena
No. of children with:
Hb <8 g/dl             Hb <5 g/dl
Variable No. of children Mean Hbb (g/dl)
a P–values are from tests of the association between prevalence of anaemia of different levels or mean haemoglobin and each of the variables in the table.
All tests are adjusted for the clustered nature of the data.
b Hb = haemoglobin concentration.
c Figures in parentheses are percentages.
d Figures in italics are standard errors.
e HAZ = height-for-age Z-score.
f WAZ = weight-for-age Z-score.
g WHZ = weight-for-height Z-score.
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children were given a referral letter for their local health
facility. Children with a Hb <5 g/dl were encouraged to
attend a hospital urgently and help was given with their
transportation where necessary. 
The study received ethical clearance from the institu-
tional review board of the Ifakara Health Research and
Development Centre (IHRDC) and the national Tanzanian
Medical Research Co-ordinating Committee. After two weeks
of training, four teams of four interviewers conducted the sur-
vey, each with a car, a driver, and a set of measuring devices.
In July 1999 the teams started work in Kilombero, at a rate of
one cluster per team per day, moving on together through
Morogoro Rural, Rufiji, and finally, Ulanga district, where
the survey was completed in August 1999. The performance
of haemoglobinometers was assessed every day using the man-
ufacturer’s checking device: if the check measure was out of
range the machine was not used. Apart from daily visual
inspections, scales, height sticks, and length boards were
cross-checked with each other every two weeks. 
Data analysis
Data were double-entered and verified using FoxPro (version
2.6, Microsoft Corporation, Seattle, WA, USA) at IHRDC.
Checks for internal consistency and referential integrity were
performed before analysis in Stata (version 6, Stata
Corporation, College Station, TX, USA). Weight-for-age
(WAZ), height-for-age (HAZ), and weight-for-height
(WHZ) Z-scores were generated using the EPINUT
module of EPI-Info version 6.0 (Centers for Disease Control
and Prevention, Atlanta, GA, USA). The analysis took into
account the clustered nature of the data using design-based
F-tests, and logistic regression for binary outcomes, using
standard STATA commands such as “svytab”, “svymean”,
and “svylogit”. A relative measure of socioeconomic status
was developed, as described in detail elsewhere (36, 37).
Briefly, principal components methodology was used to gen-
erate a score based on household ownership of assets (radio,
bicycle, tin roof, mosquito net, the house itself, livestock),
availability of one or more incomes, and the educational
level of the household head and of the child’s normal care
provider. Cross-validation between the resulting socioeco-
nomic score and height-for-age, known to be strongly asso-
ciated with socioeconomic status, confirmed that the score
was a better predictor of height-for-age than any single com-
ponent alone. The Haversine formula (38) was used to esti-
mate the distance between the centre of the cluster in which
each child lived and the nearest blood transfusion centre.
Vaccination coverage rates were calculated for children
aged 365–729 days and were based either on documentation
in the children’s Road to Health card or, where not available,
on the vaccination history as reported by the mother. The
altitude of each cluster was estimated using MapInfo® to
position clusters on a Tanzanian contour map (contour
interval of 304 m). 
Results
A total of 2417 households were selected from the 125  clus-
ters. A small number of households declined to take part
(n = 25; 1%) or were unavailable for interview (n = 142; 6%).
2131 children <5 years old were identified in 1405 house-
holds, and haemoglobin results were available for 1979 (93%)
of them. Half of the children (996) were male (Table 1) and
the sample was broadly representative of the population with
regard to age and sex of the children included (data not
shown).
Table 1 summarizes basic descriptive information and
the factors significantly associated with an Hb <11 g/dl.
Haemoglobin concentrations ranged from 1.7 to 18.6 g/dl,
with the highest Hb recorded in a neonate and the lowest
recorded in a child of 2 months. Overall, 87% (1722/1979)
of children had some degree of anaemia (Hb <11 g/dl), 39%
(775) had an Hb <8 g/dl, and 3% (65) had an Hb <5 g/dl.
Fig. 1 shows that the prevalence of all levels of anaemia rose
dramatically between 1 and 5 months of age before peaking
in children aged 6–11 months. The prevalence of anaemia
climbed from 85% (187/221) in the first 6 months of life to
96% (216/226) in the second half of infancy. Of note: 10%
Table 2. Frequency and pattern of morbidity by level of anaemia in Tanzanian children aged <5 years
>11.0 111/257 (43)a 67/109 (61)a 62/257 (24)a 28 (47)a 35 (58)a 5 (8)a 2 (3)a 3 (5)a 1 (2)a 60
8–10.9 477/941 (51) 353/469 (75) 224/941 (24) 120 (55) 147 (68) 28 (13) 8 (4) 25 (12) 10 (5)c 217
5–7.9 411/707 (58) 300/409 (73) 227/706 (32) 154 (68) 143 (64) 33 (15) 21 (9) 22 (10) 21 (10)d 225
<5.0 44/64 (69) 32/43 (74) 29/64 (45) 24 (86) 26 (93) 8 (29) 4 (14) 7 (25) 4 (14) 28 
Overall 1043/1969 (53) 751/1029 (73) 542/1968 (28) 326 (62) 351 (66) 76 (14) 35 (7) 68 (13) 36 (7)e 5
F =25.6 F =1.7 F =17.1 F =21.5 F =3.2 F =4.69 F =7.5 F =9.9 F =9.8
P<0.0001 P=0.2g P=0.0001 P<0.00001 P=0.076 P=0.03 P=0.007 P=0.002 P=0.002
Fever Cough
Fast brea-
thing
Very
sleepy
Vomiting
every-
thing
Unable 
to
drink
Denomi-
natorb
Symptom profile
Haemoglobin
concentration
(g/dl)
Sick in
past 2
weeks
Help sought
outside the
home
Sympto-
matic at
interview 
Test of sta-
tistical asso-
ciationf
a Numbers in parentheses are percentages. The row percentages exceed 100% as each child may experience more than one symptom.
b Unless otherwise stated.
c Denominator = 216.
d Denominator = 213.
e Denominator = 527.
f All tests were design-based F-tests for trend.
g Anaemic versus non-anaemic: design-based F1,123=8.1; P=0.0051.
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(22/226) of children aged 6–11 months had an Hb <5 g/dl.
There were no sex differences in mean haemoglobin
(P = 0.26) or prevalence of anaemia at any level. Approxi-
mately three-quarters of the children lived within 90 minu-
tes of their nearest health facility. Overall, 11% (211/1963)
had been admitted to hospital at least once in the previous
year and anaemic children were not more likely to have been
admitted than non-anaemic children (23/255 (9%) versus
188/1708 (11%), F = 0.84, P = 0.36). Compliance with the
full diphtheria -petussis -tetanus (DPT) and measles vaccina-
tion regimen was 82% (327/400) and not associated with
risk of anaemia.
The risk of severe anaemia (Hb <8 g/dl) increased as the
socioeconomic score decreased, the poorest children being
1.23 times as likely as the least poor to have severe anaemia
(F = 4.94, P = 0.028). Low HAZ, WHZ, and WAZ scores
were all associated with an increased risk of anaemia. Only 1
of the 188 children (0.5%) living above 1000 m had an Hb
<5g/dl, compared with 64 of the 1791 (3.5%) children liv-
ing at lower altitudes (F1,124 = 5.71, P = 0.02). Although
86% of children lived within 50 km (approximately one day
travelling) of the nearest health facility capable of giving
blood transfusions, those living more than 50 km from such
a facility were more likely to be anaemic, and this trend was
significant (Table 1). Children who spent the night before
the survey under a mosquito net, particularly a net treated
with insecticide, were up to 29% (95% confidence interval
(CI) 7 to 45) less likely to be anaemic than children who had
not slept under a net (Table 1). 
Table 2 summarizes the frequency and type of symp-
toms, and pattern of health-seeking behaviour, by level of
anaemia. More than half of the children had been unwell
during the two weeks preceding, or on the day of, the
interview. Children with a history of recent illness were more
likely to be anaemic than children with no reported illness,
the relative risk being 1.28 (95% CI=1.14 to 1.42) and 1.99
(95% CI=1.17 to 3.40) for Hb <8 g/dl and Hb <5 g/dl,
respectively. Increasing severity of anaemia was significantly
asso-ciated with symptoms at the time of interview, but
between half and three-quarters of all anaemic children were
asymptomatic. Only 4 of the 762 children (0.5%) with
any degree of anaemia and who had not been unwell in the
preceding two weeks were symptomatic on the day of the
interview.
The minority of anaemic children who were unwell
when interviewed had nonspecific symptoms. Fever, cough,
fast breathing, being very sleepy, vomiting everything, and
being unable to drink/breastfeed as normal were all more fre-
quently reported in children with anaemia than in children
without anaemia. Diarrhoea, difficult breathing, and con-
vulsions were reported with similar frequencies for anaemic
and non-anaemic children. Increasing anaemia was associat-
ed with perceived severity of the episode among children
reported to have been ill in the past two weeks. However,
67% (29/43) of mothers of symptomatic children with an
Hb <5g/dl, and 81% (365/451) of mothers of symptomatic
children with an Hb <8 g/dl, did not think the illness was
severe (Fig. 2). Mothers of anaemic children were more like-
ly to seek health care outside the home than mothers of chil-
dren with no anaemia (Table 2). No assistance was sought
for approximately 26% (237/923) of children in each cate-
gory of anaemia, despite the fact that only 31% (70/225) of
these children lived more than 90 minutes away from the
nearest health facility. 
Table 3 shows that more anaemic children used anti-
malarial drugs in the two weeks preceding the interview than
non-anaemic children. However, only 19% (320/1720) of
anaemic children had received antimalarial treatment and
less than 1% had received iron in the preceding fortnight.
Only 12% (51/425) of attendances to a formal health
provider were to a hospital, including one of the 24 children
with an Hb <5 g/dl. None of the remaining 23 children had
been referred for hospital care. 
Discussion 
Overall, 87% of children under 5 years of age had some level
of anaemia (Hb <11 g/dl). We found surprisingly few differ-
ences between anaemic and non-anaemic children (apart
from anaemia affecting relatively poor and malnou-rished
children), making it hard to identify them as a group for tar-
geted interventions. The most striking observation was the
marked age-dependence within the community, the preva-
lence of anaemia increasing dramatically during the first 6
months of life and reaching maximal levels in the  second half
of infancy. This pattern was seen for all levels of anaemia and
may reflect inadequate fetal iron stores,   secondary to mater-
nal anaemia and iron deficiency, which are then compound-
ed by additional insults (14–19). Concerns about the high
prevalence of anaemia are     heightened by the fact that most
Fig. 1. Prevalence of anaemia in children under 5 years Fig. 2. Mothers’ perceived severity of child’s illness (normal,
moderate, or severe), by level of anaemia
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children were at risk of acute malaria, which may further
reduce haemoglobin levels to a point where physiological
compromise is inevitable. In particular, the one in ten chil-
dren aged 6–11 months who were at home with an Hb <5
g/dl would have been at serious risk of life-threatening illness
if they became acutely unwell. Illness was common in the
communities surveyed, with more than half of the children
reporting an illness during the preceding two weeks (36). 
The importance of anaemia prevention, rather than
cure, is emphasized by first, the huge burden of anaemia;
second, its frequently asymptomatic nature, and nonspecific
symptoms when they do exist; third, the problems of ma-
king an accurate diagnosis; fourth, the inadequate treatment
rates, using antimalarials and iron; and fifth, the difficulties
accessing transfusion centres and the dangers associated with
transfusion. These problems are considered below and
approaches to the prevention of anaemia are discussed. 
Lack of clear symptoms
Anaemia is difficult to recognize both at the home and at
peripheral health facilities. Most anaemic children
(50–75%) were asymptomatic on the day of interview. It is
possible that some of these children were recovering from a
symptomatic illness that had caused or exacerbated the
anaemia. However, very few children (4/762 (0.5%)) with
any degree of anaemia and who had not been unwell in the
preceding two weeks were symptomatic on the day of the
interview, suggesting that their anaemia was not primarily
the result of a recent illness and thus supporting the notion
that anaemia is usually asymptomatic. This is also in keep-
ing with an earlier study in which a quarter of anaemia
episodes in a cohort of children with good access to health
care were detected only at cross-sectional surveys (18). When
symptoms were reported they were nonspecific: fever, cough,
fast breathing, being very sleepy, vomiting everything, and
being unable to drink or breastfeed as normal — these
symptoms of ill-health are shared with many other diseases.
Nevertheless, many mothers sought health care outside the
home when their child was sick and there was reasonable
access to primary health services. 
Treatment with antimalarials and iron
Difficulty in diagnosing anaemia or inadequate knowledge
of treatment guidelines may account for the low antimala-
rial (13%) and very low iron (1%) treatment rates in
anaemic children. Both types of drug are recommended by
IMCI for the treatment of anaemia in such settings (39).
Although problems of drug prescription, availability, and
cost may also account for the low prescription rates, the fact
that none of the 23 children with an Hb <5 g/dl who pre-
sented to a peripheral health facility was referred to hospital
also suggests a problem at an earlier stage in the management
pathway. Key areas for improving case management are thus
likely to be enhanced diagnosis and improved treatment of
cases. IMCI has the potential to improve this by increasing
the number of children identified as anaemic, ensuring drug
treatment guidelines are clear, and encouraging appropriate
referral practices. 
Access to transfusion centres 
The assessment of access to transfusion centres suggested
that only 19% of children lived within 10 km (approxi-
mately 2 hours travelling) of their nearest transfusion centre.
Blood transfusion is recommended for children with life-
threatening anaemia (Hb <4 g/dl) or less severe anaemia
with signs of physiological compromise (40, 41). Transfu-
sions were found to be necessary in 13–20% of general  pae-
diatric admissions (10, 42) and almost half the malaria
admissions in children aged 1–4 months in one hospital-
based study (7). However, such hospital-based data tell us
little about the number of child deaths that may be averted
by timely blood transfusion, as the majority of child deaths
occur in the community (34). Clearly, extended journey
times with a child in urgent need of transfusion are likely to
increase the risk of an adverse outcome. The increased preva-
lence of anaemia with increasing distance from transfusion
centres was therefore particularly disturbing. Although the
reason for this association is not clear, one can speculate
confounding associations between socioeconomic status
and proximity to malaria-vector breeding sites with increas-
ing distance from transfusion centres, which are typically
located in more urban settings.
Approaches to the prevention of anaemia
There is good evidence that the anaemia seen in this and
similar settings is caused largely by malaria or by iron defi-
ciency, or both (18, 19), and hence improved malaria con-
trol and iron supplementation programmes could have dra-
matic anti-anaemia effects. 
Anaemia control in mothers
One approach to preventing anaemia in children is by
reducing anaemia and improving iron status in pregnancy
and pre-pregnancy. Iron supplementation and intermittent
preventive malaria treatment are recommended for women
attending antenatal clinics (33, 43), although the transient
nature of pregnancy may result in incomplete correction of
anaemia or iron deficiency before delivery. Furthermore,
women tend to present to clinic relatively late in pregnancy
and there is evidence that anaemia in the first trimester
reduces fetal growth and birth weight (44). Novel attempts
to improve the health of prepregnant women — for exam-
>11 (n=257) 11 (4)b 12 (5)b 1 (0.4)b
8.0–10.9 (n=946) 100 (11) 50 (5) 4 (0.4)
5.0–7.9 (n=710) 112 (16) 40 (6) 6 (0.8)
<5.0 (n=64) 14 (22) 4 (6) 2 (3)
Total (n=1977) 237 (12) 106 (5) 12 (0.6)
Test of signifi-
cancec
F =32.7 F =0.43 F =3.0
P<0.00001 P=0.5 P=0.08
Haemoglobin
concentration
(g/dl)
Antimalarial drugs
Irona
Obtained
from formal
health sector
Obtained 
outside formal 
health sector
Table 3. Reported use of antimalarial drugs and iron  in the
previous 2 weeks in Tanzanian children aged <5 years
a Only one child (with a haemoglobin concentration <5 g/dl) obtained iron 
outside the formal health sector.
b Figures in parentheses are percentages.
c Design-based F–test on 1124 degrees of freedom.
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ple, by accessing newlyweds at marriage registries (45) —
have shown promise in some settings.
Iron supplementation in children
The global guidelines for iron supplementation in childhood
may need to be refined if the benefits from iron prophylaxis
are to be optimized. With the exception of children of low
birth weight, for whom iron supplements are recommended
from 2 months of age, WHO/UNICEF/INACG recom-
mend that supplementation should commence only at 6
months; however, by this age anaemia has already affected a
large proportion of children. A study from the same area as
our survey delivered iron supplements to children aged 2–6
months and showed a 29% reduction in the incidence of
severe anaemia (packed cell volume <25% (Hb <8 g/dl)) in
the first year of life (18). This supplementation regimen also
reduced the prevalence of iron deficiency measured at 12
months of age and the prevalence of anaemia at 4 years of
age (C. Menendez, D. Schellenberg, L. Quinto, E. Kahigwa,
L. Alvarez, J. J. Aponte, et al., unpublished data). 
Malaria prevention in children
Anaemia was less of a problem at altitudes greater than
1 000 m, which probably reflects the reduced burden of
malaria at such heights. Interestingly, this effect was more
marked for life-threatening anaemia than for less severe
anaemia. This suggests that malaria may be a relatively
important cause of the most severe anaemia but that other
causes of less severe anaemia, such as iron deficiency, are still
prevalent at altitude. An element of altitude-induced
secondary polycythaemia may also be present, although
this is unlikely at the altitudes studied. Children sleeping
under mosquito nets, especially nets treated with insecticide,
had a reduced risk of anaemia, which is a further indication
that malaria may be important in causing anaemia. This is in
keeping with the results of several randomized studies
that showed a mean increase in packed cell volume of 1.4%
in children sleeping under an ITN (31). A major challenge
is to develop and expand sustainable approaches to the
provision of mosquito nets — and net treatment — in
endemic settings, and progress in this respect is being made
(46). Malaria vector control by residual house-spraying has
also been shown to reduce the prevalence of anaemia (47);
however, the benefits of this approach over ITN are not
clear, especially considering the logistic complexity and
expense of house-spraying. Similarly, malaria chemoprophy-
laxis has been shown to reduce the risk of anaemia by up to
60% (18) but the logistic complexity, expense, concerns over
drug resistance, and a rebound increase in malaria and
anaemia on stopping chemoprophylaxis render this an
impractical public health approach to controlling anaemia. 
Expanded Programme on Immunization
There is an established channel capable of delivering effec-
tive anti-anaemia interventions to the target group. The
Expanded Programme on Immunization (EPI) routinely
delivers DPT and oral polio vaccines to children aged 1, 2,
and 3 months, and measles vaccinations and vitamin A sup-
plements to children aged 9 months. Children with the most
severe anaemia were just as likely as others to receive routine
EPI vaccinations and overall compliance with the full DPT
and measles vaccination regimen was high (82%). This
existing infrastructure already delivers vaccines and
micronutrients to the target group for anaemia control. In
particular, it has contact with children during the first 6
months of life, when the prevalence of anaemia is rising
sharply and may therefore be most amenable to interven-
tion. This principle was confirmed by a study investigating
the effects of intermittent malaria treatment delivered at 2,
3, and 9 months of age, in which the incidence of anaemia
(Hb <8 g/dl) was reduced by 50% in the first year of life
(48). This study also monitored compliance to ferrous
sulfate supplements, made available at the time of routine
health visits between 2 and 6 months of age, which may be
another feasible approach to anaemia control. 
Study limitations
This study was subject to the limitations of any retrospective
study, such as the reliance on a history of illness and its
inherent biases. We related a history of illness and treatments
in the two weeks preceding interview to the haemoglobin
concentration at the time of the survey. Haemoglobin levels
could have fluctuated during the intervening period, there-
by crossing the thresholds defining “any”, “severe” and “life-
threatening” anaemia in either direction. However, the
extremely high prevalence of anaemia at all levels, despite the
large number of contacts with the health services (Table 2),
suggests that the effects of such misclassifications are likely
to be relatively small and that there is considerable scope for
improvements in anaemia control. Another limitation of this
study is that it was performed over a period of only 2 months
in the early dry season, and hence seasonal variations in the
pattern of anaemia could not be discerned.
Conclusion
In conclusion, we have documented a very high point preva-
lence of anaemia in children under 5 years and showed that
children less than 6 months of age are already severely
affected. Anaemia was usually asymptomatic and when
symptoms arose they were nonspecific. Few anaemia cases
were managed optimally, despite many children having
attended a health facility, and the very high burden of
anaemia warrants a concerted approach to its control.
Improved availability of diagnostic tests and wider imple-
mentation of standard treatment guidelines, including
appropriate referral practices and optimizing compliance, are
important. However, given the insidious and often unde-
tected nature of anaemia, the difficulties accessing appro-
priate health care, and the dangers of blood transfusion,
increased emphasis on preventive measures is required. The
system of EPI contacts may be a suitable means of raising
awareness about anaemia and delivering effective anaemia
control interventions. 
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Resumen
La carga silenciosa de anemia entre los niños de Tanzanía: un estudio comunitario
Résumé
L’anémie silencieuse chez les enfants tanzaniens : une étude en communauté
Objectif Documenter la prévalence, la répartition par âge et les
facteurs de risque d’anémie chez les enfants tanzaniens de moins
de 5 ans, en aidant ainsi à l’élaboration de stratégies efficaces de
lutte contre l’anémie.
Méthodes Un sondage en grappes a été réalisé au milieu de l’an-
née 1999 afin de recenser de manière aléatoire 2417 ménages
dans quatre districts contigus du sud-est de la République-Unie de
Tanzanie. Des données relatives à différents paramètres sociaux et
médicaux ont été recueillies et analysées.
Résultats On a disposé du taux d’hémoglobine (Hb) de 1979
enfants sur les 2131 (93 %) recensés et il se situait entre 1,7 et
18,6 g/dl. Dans l’ensemble, 87 % (1722) des enfants avaient un
taux d’hémoglobine <11 g/dl, 39 % (775) un taux <8 g/dl et
3 % (65) un taux <5 g/dl. Pour ces trois degrés d’anémie, la pré-
valence la plus forte a été retrouvée chez les enfants âgés de 6 à
11 mois, dont 10 % (22/226) avaient un taux d’hémoglobine  <5
g/dl. Toutefois, la prévalence de l’anémie était déjà élevée chez les
enfants âgés de 1 à 5 mois (85 % d’entre eux montraient une Hb
<11 g/dl, 42 % une Hb <8 g/dl et 6 % une Hb <5 g/dl). Cette
anémie était en général asymptomatique et lorsque des symptô-
mes apparaissaient, ils étaient non spécifiques et rarement ratta-
chés à une pathologie grave par le dispensateur de soins. Des anté-
cédents récents de traitement par les antipaludiques et de complé-
mentation martiale étaient rares. L’observance du calendrier d’ad-
ministration du Programme élargi de vaccination (PEV) était de 82
% et n’était pas associée à un risque d’anémie.
Conclusion L’anémie est extrêmement fréquente dans le sud-est
de la République-Unie de Tanzanie, même chez les très jeunes
nourrissons. De plus, la mise en oeuvre de l’algorithme de Prise en
charge intégrée des maladies de l’enfance devrait améliorer la
prise en charge des cas d’anémie. Toutefois, la nature asymptoma-
tique de la plupart des épisodes rencontrés souligne la nécessité de
disposer de stratégies de prévention. Le PEV a une bonne couver-
ture de la population cible et il pourrait constituer un canal appro-
prié par lequel fournir des instruments permettant de lutter contre
l’anémie et le paludisme.
Objetivo Documentar la prevalencia, la distribución por edades
y los factores de riesgo de la anemia entre los niños tanzanos
menores de 5 años, a fin de ayudar a formular estrategias efica-
ces para controlar la anemia.
Métodos A mediados de 1999 se identificaron aleatoriamente
mediante muestreo por conglomerados 2417 hogares de cuatro
distritos contiguos del sureste de la Républica Unida de Tanzanía.
Se reunieron y analizaron datos sobre diversos parámetros socia-
les y médicos.
Resultados Se consiguieron las concentraciones sanguíneas de
hemoglobina (Hb) de 1979 (93%) de los 2131 niños identifica-
dos, con valores de entre 1,7 y 18,6 g/dl. En términos globales, el
87% (1722) de los niños poseían una concentración de Hb < 11
g/dl, el 39% (775) < 8 g/dl, y el 3% (65) < 5 g/dl. La prevalencia
más alta de esos tres grados de anemia se halló en los niños de
6–11 meses, el 10% (22/226) de los cuales presentaba una
concentración de Hb < 5 g/dl. Sin embargo, la prevalencia de ane-
mia ya era alta en los niños de 1–5 meses (el 85% presentaba
una Hb < 11 g/dl, el 42% < 8 g/dl, y el 6% < 5 g/dl).
La anemia era por lo general asintomática, y en los casos en
que había síntomas éstos eran inespecíficos y rara vez concep-
tuados como enfermedad grave por el dispensador de atención.
Pocas veces se registraron antecedentes recientes de tratamien-
to con antimaláricos y hierro. El cumplimiento de las vacuna-
ciones dispensadas a través del Programa Ampliado de
Inmunización (PAI) era del 82% y no se asoció a riesgo alguno
de anemia.
Conclusión La anemia es un problema muy común en el sures-
te de la Républica Unida de  Tanzanía, incluso entre los lactantes
de muy corta edad. Una más extensa aplicación del algoritmo de
la Atención Integrada a las Enfermedades Prevalentes de la
Infancia debería redundar en la mejora del manejo de los casos
de anemia. No obstante, el carácter asintomático de la mayoría
de los episodios de anemia destaca la necesidad de aplicar estra-
tegias preventivas. El PAI, con una buena cobertura de la 
población destinataria, podría ser un mecanismo apropiado para
suministrar los medios necesarios para controlar la anemia y la
malaria.
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